Alar Pharmaceuticals Inc. (TPEX: 6785)

Alar Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,120	11,942	6,555	2,608	2,793	-
Market Cap Growth	35.91%	82.17%	151.37%	-6.63%	-	-
Enterprise Value	7,696	11,326	6,046	2,053	2,171	-
Last Close Price	151.50	208.35	114.37	45.50	48.73	-
PE Ratio	25.18	31.21	-	-	-	-
PS Ratio	21.27	25.45	8193.75	-	4655.00	-
PB Ratio	4.25	13.31	12.74	4.88	4.67	-
P/TBV Ratio	4.91	13.31	12.74	4.88	4.67	-
P/FCF Ratio	46.47	30.06	-	-	-	-
P/OCF Ratio	54.97	29.59	-	-	-	-
EV/Sales Ratio	16.23	24.14	7557.22	-	3617.60	-
EV/EBITDA Ratio	20.01	29.22	-	-	-	-
EV/EBIT Ratio	20.21	29.38	-	-	-	-
EV/FCF Ratio	35.34	28.51	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	-	-	-	-
Debt / FCF Ratio	0.00	0.00	-	-	-	-
Asset Turnover	0.30	0.63	0.00	-	0.00	-
Quick Ratio	44.92	11.98	90.70	116.51	135.92	50.27
Current Ratio	45.14	12.08	92.66	118.67	143.31	53.93
Return on Equity (ROE)	27.11%	54.21%	-3.79%	-11.34%	-36.17%	-30.19%
Return on Assets (ROA)	15.10%	32.22%	-5.47%	-10.19%	-26.68%	-16.35%
Return on Capital (ROIC)	16.30%	34.04%	-5.53%	-10.27%	-26.90%	-16.95%
Earnings Yield	3.97%	3.20%	-0.30%	-2.46%	-5.11%	-
FCF Yield	2.15%	3.33%	-0.52%	-2.49%	-5.10%	-
Dividend Yield	0.98%	0.72%	-	-	-	-
Buyback Yield / Dilution	-16.89%	-0.09%	-	-14.21%	-42.59%	-27.77%
Total Shareholder Return	-15.91%	0.63%	-	-14.21%	-42.59%	-27.77%

Source: S&P Capital IQ. Standard template. Financial Sources.